Hos patienter med psoriasis artrit blev der påvist anti- adalimumab antistoffer hos 38/ 376 patienter (10%) behandlet med adalimumab.
In patients with psoriatic arthritis, anti-adalimumab antibodies were identified in 38/ 376 subjects (10%) treated with adalimumab.